Close
Xylem
Novotech

Press Releases

Dr. Reddy’s Laboratories Announces Launch of the Sputnik V vaccine inthe Indian Market

Dr. Reddyโ€™s Laboratories Ltd. announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on 1stMay, 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on 13th May, 2021. As part...

Envirotainer launches the Releye RLP – simpler than passive, even better than active

Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, launched their latest innovation, the Releyeยฎ RLP, a temperature-controlled air freight container with a revolutionary new footprint, unsurpassed autonomy, fully integrated live monitoring, and...

21st Edition Strategic Project & Portfolio Management for Pharma

The economic turmoil has taken a toll on pharma and biotech companies who have been confronted by stringent regulations and budget cuts in R&D. Furthermore, Covid-19 and the related crisis has made the need for better prioritization and faster...

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

Pfizer Inc. and BioNTech SE announced today that the U.S. FDA has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in...

GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 for the Early Treatment of COVID-19

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the EMA has started a rolling review of data on sotrovimab, an investigational dual-action SARS-CoV-2 monoclonal antibody, for the treatment of adults and adolescents (aged 12 years and over and weighing...

Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19

Vectura Group plc, an industry leading inhalation CDMO, and Inspira Pharmaceuticals Limited, a new UK-based company focused on developing therapies for respiratory and infectious diseases, announced an agreement to develop an inhaled formulation of Inspiraโ€™s lead drug candidate for...

Cryoport and LabConnectPartner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial

LabConnect, Inc. and Cryoport, Inc. announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป